How to Increase HDL Cholesterol and Improve HDL Quality

Raising your HDL cholesterol is possible through a combination of exercise, dietary shifts, weight management, and quitting smoking, but the more important lesson from the past two decades of research is that the number on your blood test tells only part of the story. Multiple large studies have found that how well your HDL particles ferry cholesterol out of artery walls predicts heart disease risk better than the raw HDL level itself. That distinction between HDL quantity and HDL quality reshapes how you should think about every strategy aimed at boosting this lipoprotein.

Why HDL Quality Matters More Than the Number

For years, the goal was simple: get your HDL above 40 mg/dL if you’re a man, above 50 mg/dL if you’re a woman, and higher is better. That framing has shifted. A pivotal study published in the New England Journal of Medicine followed patients on statin therapy and measured not just HDL levels but cholesterol efflux capacity, which reflects how effectively HDL pulls cholesterol out of cells lining blood vessels. Even after adjusting for HDL level and particle count, participants in the highest quartile of efflux capacity had roughly a 67% lower cardiovascular risk compared with those in the lowest quartile. The HDL number itself, once traditional risk factors were accounted for, showed no independent association with events.¹

That finding has been confirmed in different populations. A case-control study in the general population found that efflux capacity was lower in people who later developed cardiovascular events, even though their HDL and apoA-I levels were identical to those of controls.² And a prospective study of coronary heart disease found that the inverse relationship between HDL level and heart disease events actually became nonsignificant once efflux capacity was factored in, while efflux capacity’s protective association held up even after adjusting for HDL concentration.³

The practical upshot: a lifestyle change that raises your HDL number by a few points and simultaneously improves how those particles function is more valuable than one that just inflates the count. Some interventions do both. Some only do one. Knowing the difference helps you focus your effort.

How HDL Actually Works Inside Your Body

HDL particles participate in what researchers call reverse cholesterol transport. Cells that have accumulated too much cholesterol use specific transporter proteins to hand it off to HDL, which then carries it back to the liver for disposal. Two key transporters handle this relay. The first, called ABCA1, loads cholesterol and phospholipids onto small, lipid-poor particles. The second, ABCG1, adds cholesterol to HDL particles that are already partially loaded, fattening them up into mature, cholesterol-rich forms.⁴ Mutations that disable ABCA1 cause Tangier disease, a rare condition marked by nearly undetectable HDL levels and cholesterol buildup in tissues.⁵

Beyond hauling cholesterol, HDL particles protect blood vessel linings in several other ways. They carry antioxidant enzymes, reduce inflammation, inhibit blood clotting, and stimulate nitric oxide production, which keeps arteries relaxed and flexible.⁶ When any of these functions deteriorate, as they do with chronic smoking or poorly controlled diabetes, your HDL particles become less protective even if their total count stays the same.

Exercise Raises HDL, but Intensity and Volume Both Matter

Aerobic exercise is probably the most reliable lifestyle lever for raising HDL. The challenge is that the dose matters. Light or moderate exercise at low volumes may improve cardiovascular fitness without meaningfully moving HDL numbers. A clinical trial comparing different exercise intensities and amounts found that HDL cholesterol increased significantly in the group assigned to high-amount, vigorous-intensity exercise, while other groups saw no significant HDL change.⁷ The increase was modest, around 3 mg/dL, but it came with improvements in HDL function measures as well.

For most people, this translates to a practical threshold: you need regular, sustained aerobic work at a pace that genuinely pushes your heart rate, not just leisurely walks. Running, cycling, swimming laps, or vigorous hiking several times a week tends to be more effective than the same total minutes spent at a gentle pace. That said, any movement is better than none, and even moderate exercise confers cardiovascular benefits through mechanisms that go beyond the HDL number alone.

What You Eat Changes Both HDL Level and HDL Function

The dietary picture is more nuanced than “eat healthy fats.” A few specific patterns stand out.

Cutting refined carbohydrates and added sugars appears to have a larger effect on HDL than simply swapping one type of fat for another. When saturated fat in the diet is replaced by refined carbohydrates, triglycerides rise and HDL drops.⁸ A randomized trial comparing a low-carbohydrate ketogenic diet with a low-fat diet in obese individuals with high cholesterol found that the low-carb group gained roughly 5.5 mg/dL in HDL over six months, while the low-fat group actually lost about 1.6 mg/dL.⁹ Longer-term ketogenic diets in obese people with high cholesterol have also shown significant HDL increases alongside drops in triglycerides, LDL, and blood glucose.¹⁰ The low-carb group also showed favorable shifts in lipoprotein particle size, including a 21% increase in large HDL particles and smaller, denser LDL particles shrinking by 78%.¹¹

As for the type of fat, swapping saturated fat for either monounsaturated or polyunsaturated fat lowers LDL, but neither swap reliably raises HDL. A meta-analysis comparing monounsaturated and polyunsaturated fat diets found no significant difference between them on HDL or LDL levels, and neither raised HDL compared with higher-saturated-fat diets.¹² In short, the HDL payoff from dietary fat swaps is mostly about avoiding the damage that refined carbohydrates do, not about finding a magic oil.

Olive Oil and HDL Function

One exception worth highlighting is extra virgin olive oil, specifically its polyphenol content. While olive oil’s fat profile (predominantly monounsaturated) doesn’t raise HDL numbers on its own, its polyphenols appear to improve HDL function directly. A randomized controlled trial gave participants olive oil that was either rich or poor in polyphenols. After the polyphenol-rich intervention, cholesterol efflux capacity increased by about 3%, HDL particles grew larger, their cores became less loaded with triglycerides, and they carried more antioxidant polyphenol metabolites. The polyphenol-poor olive oil produced none of these benefits.¹³ Lab work supports the mechanism, showing that polyphenols in extra virgin olive oil promote cholesterol efflux through the ABCA1 pathway and protect lipoproteins from oxidative damage.¹⁴

This is a useful example of the quantity-versus-quality distinction in action. The polyphenol-rich olive oil didn’t necessarily push the HDL number higher on a blood test, but it made existing HDL particles better at their job. A similar finding emerged in elderly heart attack survivors, where high-polyphenol extra virgin olive oil increased paraoxonase-1 activity, an antioxidant enzyme carried by HDL.¹⁵

Smoking, Weight, and Alcohol

Quitting smoking improves HDL function even if the HDL number on your blood test doesn’t move much. A study of successful quitters found that HDL cholesterol, apoA-I, and HDL subfractions didn’t significantly change after cessation, but cholesterol efflux capacity and HDL’s antioxidant capacity both improved meaningfully.¹⁶ Smoking damages a specific antioxidant enzyme associated with HDL called paraoxonase. In patients with coronary artery disease, ex-smokers who had quit within the past three months still had enzyme levels similar to current smokers, but levels recovered to those of never-smokers within two years.¹⁷ If you’ve recently quit and your HDL hasn’t budged, the invisible repairs are already underway.

Losing excess weight, particularly visceral fat around the organs, raises HDL. A study in obese postmenopausal women found that those who maintained reduced belly fat after a weight loss intervention also maintained higher HDL and lower triglycerides over the long term.¹⁸ The relationship runs both ways: the HDL increase itself served as a marker that the visceral fat loss was being sustained.

Alcohol raises HDL in a dose-dependent fashion. Moderate consumption increased HDL by roughly 18% in a controlled study, driven by faster production of the main HDL-associated proteins, apoA-I and apoA-II.¹⁹ Even relatively short-term moderate drinking raised HDL by about 7% within ten days in another study.²⁰ However, the cardiovascular risks of alcohol, including high blood pressure, liver disease, and cancer, generally outweigh the HDL benefit. No major medical organization recommends starting to drink for heart health, and if you already drink, the HDL effect is not a reason to increase.

Why Drugs That Raise HDL Have Mostly Disappointed

If raising the HDL number were enough to prevent heart attacks, you’d expect medications that dramatically boost HDL to save lives. They haven’t, and the story of why is one of the most instructive cautionary tales in cardiology.

Niacin (vitamin B3) is the oldest HDL-raising drug still in use. At pharmacological doses, it raises HDL substantially. In the AIM-HIGH trial, patients on intensive statin therapy received either extended-release niacin or placebo. After two years, niacin had bumped median HDL from 35 to 42 mg/dL and lowered both triglycerides and LDL. On paper, the lipid profile looked great. But the rate of heart attacks, strokes, and cardiovascular death was virtually identical in both groups, with the primary endpoint occurring in 16.4% of the niacin group versus 16.2% on placebo.²¹ Niacin raises the number without clearly improving outcomes, at least in patients already taking statins.

CETP inhibitors are a newer class of drugs that block the protein responsible for transferring cholesterol from HDL to LDL particles. The result is a dramatic increase in HDL and a decrease in LDL.²² Early CETP inhibitors failed due to safety problems or lack of benefit. Torcetrapib, the first to reach large trials, increased blood pressure and deaths. Later agents like dalcetrapib and evacetrapib were safe but didn’t reduce cardiovascular events despite raising HDL substantially. The latest entry, obicetrapib, has rekindled interest: in a phase 2 trial, it raised HDL by up to 165% and lowered LDL by up to 51% on top of statin therapy, with an acceptable safety profile.²³ But the crucial question, whether obicetrapib actually reduces heart attacks and strokes, won’t be answered until large outcome trials report their results.²⁴

Fibrates, commonly prescribed for high triglycerides, also raise HDL modestly by activating a receptor that boosts production of the HDL-associated proteins apoA-I and apoA-II.²⁵ Their main benefit is triglyceride lowering rather than HDL raising per se, and outcome trials have shown mixed results on cardiovascular events, with the most consistent benefits appearing in patients with high triglycerides and low HDL simultaneously.

The takeaway from the drug story reinforces the earlier point about function versus number. Simply inflating the HDL count, whether with niacin or early CETP inhibitors, doesn’t automatically translate to fewer heart attacks. The drugs that might eventually work (like obicetrapib) also dramatically lower LDL and apoB, so untangling how much credit goes to the HDL side remains genuinely uncertain.

The U-Shaped Curve and Very High HDL

Another surprise from recent research: very high HDL may not be protective either. Several large studies have documented a U-shaped relationship between HDL cholesterol and mortality. Both low levels (below about 40 mg/dL in men) and very high levels (above roughly 80 mg/dL) are associated with increased risk of death from cardiovascular disease, cancer, and all causes combined.²⁶ A large prospective cohort study focused on stroke found that HDL levels above about 79 mg/dL carried an 85% higher stroke risk compared with the optimal range, and even levels below about 41 mg/dL carried a 31% increased risk.²⁷

Why very high HDL might be harmful isn’t fully understood. One hypothesis is that at extreme concentrations, HDL particles become dysfunctional, losing their anti-inflammatory and antioxidant properties. Genetic variants that push HDL very high don’t necessarily protect against heart disease, which suggests the particles accumulating aren’t doing useful work. A review in Current Cardiology Reports noted that both very low and very high HDL are linked to elevated cardiovascular and all-cause mortality independent of traditional risk factors.²⁸ For most people, this means there’s a sweet spot for HDL rather than a simple “higher is better” rule. If your HDL is naturally very high and you’ve been told that’s always great news, the picture is more complicated than it used to be.

Hormonal Shifts and HDL Across the Menopause Transition

Women typically carry higher HDL than men, largely because of estrogen’s effects on lipoprotein metabolism. Menopause disrupts that advantage in ways that go beyond a simple number drop. A longitudinal study tracking women across the menopause transition found that within one to two years of the final menstrual period, large HDL particles and overall HDL size declined, while small HDL particles and HDL-associated triglycerides increased. The overall efflux capacity per HDL particle actually fell during this window, even though total efflux capacity, measured across all particles, went up slightly.²⁹

This means that perimenopause and early postmenopause are periods when HDL quality deteriorates even if the blood test number looks stable. The shift toward smaller, triglyceride-laden particles is a pattern associated with higher cardiovascular risk. For women in their late 40s and 50s wondering why their risk profile seems to worsen despite an unchanged HDL number, this remodeling of HDL composition is part of the answer. It also means that the lifestyle strategies discussed earlier, especially vigorous exercise and carbohydrate moderation, may be particularly worthwhile during the menopause transition.

The Gut Microbiome Connection

Emerging research from the Framingham Heart Study has linked specific gut bacteria and their metabolic products to HDL levels. A metabolomics analysis found that short-chain fatty acids produced by gut bacteria, particularly butyrate and propionate, were positively associated with HDL.³⁰ These compounds are produced when gut microbes ferment dietary fiber, which offers yet another mechanism by which a fiber-rich diet may support HDL levels. The same study identified specific cholesterol-metabolizing bacteria that may influence the whole lipid profile. This area of research is still young, and nobody should be selecting probiotic supplements based on it yet, but it does suggest that “eat more fiber” and “eat a diverse plant-rich diet” have metabolic rationale beyond the usual talking points.

Experimental Approaches on the Horizon

One of the more intriguing avenues in HDL research involves synthetic particles designed to mimic natural HDL. CER-001, a lab-made particle containing apoA-I (the main protein in HDL), was tested in patients with homozygous familial hypercholesterolemia, a rare condition causing extreme cholesterol levels despite maximum drug therapy. After 12 biweekly infusions, CER-001 produced a measurable reduction in carotid artery wall thickness, suggesting it may reverse atherosclerosis in the arterial wall.³¹ This was a small study in a rare disease population, so it’s far from proof that synthetic HDL mimetics will become mainstream treatment. But it demonstrates a fundamentally different approach: instead of trying to coax your body into making more HDL or preventing its breakdown, you inject functional particles directly. Whether this ever becomes practical for the broader population remains to be seen, but it underscores how central HDL function, rather than quantity, has become to the research field’s thinking.